Search

Search Constraints

You searched for: Author/Creator Ouyang, Haojun

Search Results

1. 250 AVXS-101 phase 3 study in spinal muscular atrophy type 1. Issue 12 (14th November 2019)

2. A Phase 2, Placebo‐Controlled Study of the Opioid Receptor Antagonist LY2196044 for the Treatment of Alcohol Dependence. (6th September 2013)

3. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial. Issue 4 (April 2021)

4. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial. Issue 10 (October 2021)